Rapid, molecular point-of-care tests can be used in remote settings to accurately detect the presence of Strep A bacterium in just six minutes.
The rapid molecular test, called N1-STOP-LAMP, involves using a small portable machine that can detect SARS-CoV-2 from just one nasal swab.
The HbA1c test measures the degree to which sugar molecules have linked irreversibly to molecules in red blood cells in the previous few months.
Blood tests based on the tau protein phospho-tau217 (p-tau217) may be able to detect changes in the brain 20 years before dementia symptoms occur.
The new test uses a single drop of blood — collected from a simple finger prick — and results are ready in a few hours.
The method has been found to detect kidney cancers with high accuracy, including small, localised tumours for which no early detection method currently exists.
A groundbreaking new test can improve the early detection of prostate cancer compared with the existing prostate-specific antigen (PSA) blood test.
Saliva can be used to diagnose the presence and transmission of COVID-19, and to monitor immunity to SARS-Cov-2.
The biomarker discovery could be used as the basis for a highly effective and simple diagnostic blood test to help detect prevalent cases of TB in the community.
The new diagnostic approach has the potential to enhance infectious diseases surveillance, and so is now being adapted to track immunity to COVID-19.
Unlike in the influenza pandemic in 1918, today we are better equipped to identify the elusive bug responsible for COVID-19.
Researchers have developed a new method to enable more timely diagnosis and treatment of urological cancers, ie, prostate, bladder and kidney cancers.
A new blood test can accurately detect more than 50 types of cancer and identify in which tissue the cancer originated, often before there are any clinical signs or symptoms.
A new infection test, made up of sheets of paper patterned by lasers, will enable diagnosis at the point of care — helping doctors give patients the right treatment, and quickly.
The nanotechnology developed by University of Queensland scientists can detect and monitor extracellular vesicles (EVs) in the bloodstream.